Multiple myeloma drug, Ninlaro, gets FDA approval
by Staff from Outbreak News Today on (#V7YT)
Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy. Multiple myeloma is a form of blood cancer that occurs in infection-fighting plasma cells (a type of white blood cell) found in the ["]
